Keywords : clinical trial, phase III clinical trial
Histogenics Corporation - Product Pipeline Analysis Summary Histogenics Corporation (Histogenics) is a regenerative medical company, based in the US. It develops and manufactures tissue regeneration products for the orthopedic markets. The company manufactures products such as VeriCart auto-regenerative cartilage matrix and NeoCart implant. Its VeriCart is a unique, ready-to-use collagen scaffold that offers an attractive alt...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
Histogenics Corporation - Product Pipeline Analysis
Summary
Histogenics Corporation (Histogenics) is a regenerative medical company, based in the US. It develops and manufactures tissue regeneration products for the orthopedic markets. The company manufactures products such as VeriCart auto-regenerative cartilage matrix and NeoCart implant. Its VeriCart is a unique, ready-to-use collagen scaffold that offers an attractive alternative for treating discrete cartilage defects. The company’s VeriCart is in Phase I clinical trial. Histogenics investigates NeoCart in Phase III clinical trial in the US. It is a three-dimensional, neocartilage implant grown from patient’s cells (chondrocytes) outside the body. The company also develops products used in sports injuries and joint replacements. Histogenics is headquartered in Waltham, Massachusetts, the US.
This report is a source for data, analysis and actionable intelligence on the Histogenics Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Drug Discovery And Development Industry in the United States
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Histogenics Corporation - Major Products and Services 5
Histogenics Corporation Pipeline Products by Equipment Type 6
Histogenics Corporation Pipeline Products by Development Stage 8
Histogenics Corporation Pipeline Products by Therapy Area 10
Histogenics Corporation Pipeline Products by Trial Phase 12
Histogenics Corporation Pipeline Products by Milestone Summary 14
BioCart Autologous Cartilage Regeneration System 16
BioCart Autologous Cartilage Regeneration System Product Status 16
BioCart Autologous Cartilage Regeneration System Product Description 16
BioCart Autologous Cartilage Regeneration System Product Milestone 16
BioCart Autologous Cartilage Regeneration System Product Patent Details 17
CartiMate Matrix-Assisted Microfracture (MAMF) System 21
CartiMate Matrix-Assisted Microfracture (MAMF) System Product Status 21
CartiMate Matrix-Assisted Microfracture (MAMF) System Product Description 21
NeoCart 22
NeoCart Product Status 22
NeoCart Product Description 22
NeoCart Product Milestone 22
NeoCart Product Patent Details 23
VeriCart 26
VeriCart Product Status 26
VeriCart Product Description 26
VeriCart Product Patent Details 26
Histogenics Corporation - Key Competitors 28
Histogenics Corporation - Key Employees 29
Histogenics Corporation - Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Histogenics Corporation, Recent Developments 31
Sep 12, 2011: Histogenics Appoints Michael Lewis As CMO And Peter Hamilton As Vice President Of Manufacturing, Production 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
Histogenics Corporation, Key Facts 1
Histogenics Corporation Key Pipeline Products by Equipment Type 1
Histogenics Corporation Key Pipeline Products by Therapy Area 1
Histogenics Corporation Key Pipeline Products by Development Stage 1
Histogenics Corporation Key Pipeline Products by Trial Phase 1
Histogenics Corporation, Key Facts 4
Histogenics Corporation, Major Products and Services 5
Histogenics Corporation Number of Pipeline Products by Equipment Type 6
Histogenics Corporation Pipeline Products by Equipment Type 7
Histogenics Corporation Number of Pipeline Products by Development Stage 8
Histogenics Corporation Pipeline Products by Development Stage 9
Histogenics Corporation Number of Pipeline Products by Therapy Area 10
Histogenics Corporation Pipeline Products by Therapy Area 11
Histogenics Corporation Number of Pipeline Products by Trial Phase 12
Histogenics Corporation Pipeline Products by Trial Phase 13
Histogenics Corporation Number of Pipeline Products By Milestone Summary 14
Histogenics Corporation Pipeline Products by Milestone Summary 15
BioCart Autologous Cartilage Regeneration System - Product Status 16
BioCart Autologous Cartilage Regeneration System - Product Description 16
BioCart Autologous Cartilage Regeneration System - Product Milestone 16
BioCart Autologous Cartilage Regeneration System - Patent Details 17
CartiMate Matrix-Assisted Microfracture (MAMF) System - Product Status 21
CartiMate Matrix-Assisted Microfracture (MAMF) System - Product Description 21
NeoCart - Product Status 22
NeoCart - Product Description 22
NeoCart - Product Milestone 22
NeoCart - Patent Details 23
VeriCart - Product Status 26
VeriCart - Product Description 26
VeriCart - Patent Details 26
Histogenics Corporation, Key Employees 29
List of Figures
Histogenics Corporation Pipeline Products by Equipment Type 6
Histogenics Corporation Pipeline Products by Development Stage 8
Histogenics Corporation Pipeline Products by Therapy Area 10
Histogenics Corporation Pipeline Products by Trial Phase 12
Histogenics Corporation Pipeline Products by Milestone Summary 14
